Continue to consider precautions related to pancreatic risk until more data are available
Absolutely, GLP 1 & GIP therapy requires special care regarding its source, handling and the quality grade of the ingredients
Tesamorelin stimulates GH release through GHRH receptor activation
In 2023, semaglutide made up 88.1% of new prescriptions in 2023, whereas liraglutide made up just 10.3%
FRJ has received consulting honoraria from Boehringer Ingelheim, Mundipharma, Astra Zeneca, Novo Nordisk, MSD, Lilly, and Sanofi.DKM has had leadership roles in clinical trials for AstraZeneca, Boehringer Ingelheim, Eisai, Esperion, GlaxoSmithKline, Janssen, Lexicon, Merck & Co., Inc., Novo Nordisk, CSL Behring, and Sanofi USA
The reported side effects appear to be similar to those reported with sermorelin [6]